InvestorsHub Logo

ggwpq

06/18/19 4:14 PM

#197401 RE: Airbaa #197397

Do you know what $80/share translates to in market cap? Do you know how many companies that currently operate in the cardiovascular arena could afford such a market cap? Single digit number at best.

CalMustang

06/18/19 4:29 PM

#197409 RE: Airbaa #197397

It depends on what stage we're in, right? Prior to approval, I think $40-60 is tenable to the market. After approval, I would think $55-75 would be a respectable offer. After >$1B in sales, if no BO has occurred by then, you are looking at a triple-digit stock price offer (assuming no further dilution, etc).

everyonesguess

06/18/19 4:57 PM

#197412 RE: Airbaa #197397

At current time, a $30 BO would be good enough (around $24 PPS on Sep 28).

For higher valuation, Amarin needs to develop new indications with Vascepa. JMHO

Greedy makes one blind-like!!!